Skip to main content
logo
Immix Biopharma, Inc. (IMMX)
NASDAQ: IMMX · Real-Time Price · USD
8.68
+0.62 (7.69%)
Nov 9, 2026, 11:27 AM EST - Market open

Immix Biopharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
720276611373247
Market Cap Growth
622.28%355.41%-55.98%331.07%-32.18%-
Enterprise Value
488261421181551
Last Close Price
8.065.232.206.922.293.56

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
2.522.944.578.492.422.61
P/TBV Ratio
2.922.944.578.382.422.61

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.000.010.08--0.00
Net Debt / Equity Ratio
-1.01-1.06-1.25-1.08-1.02-0.98
Net Debt / EBITDA Ratio
5.573.340.731.091.6413.04
Net Debt / FCF Ratio
5.914.031.051.531.8111.07
Quick Ratio
24.959.932.265.0210.7587.46
Current Ratio
25.1310.012.335.3211.7090.01
Return on Equity (ROE)
-34.18%-55.00%-147.33%-106.22%-52.84%-367.80%
Return on Assets (ROA)
-20.52%-29.30%-66.11%-57.92%-31.04%-9.02%
Return on Capital Employed (ROCE)
-18.20%-31.60%-159.00%-99.60%-60.30%-7.50%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-9.61%-10.68%-35.72%-11.22%-25.80%-51.85%
FCF Yield
-5.86%-8.95%-26.06%-8.31%-23.23%-3.38%
Buyback Yield / Dilution
-61.22%-16.55%-63.11%-24.87%-278.13%-8.82%
SEC Filings: 10-K · 10-Q